[
    [
        {
            "time": "2020-07-15",
            "original_text": "康龙化成(300759)：业绩增长超预期，业务布局持续加速【2020年中报业绩预告点评|西南医药杜向阳团队】",
            "features": {
                "keywords": [
                    "康龙化成",
                    "业绩增长",
                    "超预期",
                    "业务布局",
                    "加速",
                    "中报业绩预告",
                    "西南医药",
                    "杜向阳团队"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "康龙化成(300759)：业绩增长超预期，业务布局持续加速【2020年中报业绩预告点评|西南医药杜向阳团队】",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]